VERACYTE, INC.

VCYT
Delayed Quote. Delayed  - 01/15 04:00:01 pm
50.79USD -3.40%

Turn to zoom
Prev.52.5800
Open52.4800
High54.6400
Low50.5400
Volume679 914
Latest news
01/06
12/30
12/22
12/22
Chart VERACYTE, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance54,961,957,6
Spread/Res.-7,4%-18%-12%
Spread/Supp.7,3%19%55%
Support47,342,832,7
Financials
Sales 2020 115 M - -
Net income 2020 -33,4 M - -
Net cash 2020 335 M - -
P/E ratio 2020 -80,1x
Yield 2020 -
Capitalization 2 941 M 2 941 M -
EV / Sales 2020 22,7x
EV / Sales 2021 17,2x
Nbr of Employees 354
Free-Float 99,2%
Company
Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing...

>> Read more
Sector :
Bio Diagnostics & Testing
Calendar :
2021-03-02 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 46,20 $
Last Close Price 50,79 $
Spread / Highest target 18,1%
Spread / Average Target -9,04%
Spread / Lowest Target -31,1%